THX Pharma
ALTHX.PA · PAR
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -€1,765 | -€6,828 | -€6,567 | -€8,150 |
| Dep. & Amort. | €96 | €256 | €332 | €1,204 |
| Deferred Tax | €0 | €0 | €0 | €0 |
| Stock-Based Comp. | €0 | €0 | €0 | €0 |
| Change in WC | €594 | €255 | €1,068 | €409 |
| Other Non-Cash | -€2,294 | -€42 | -€207 | €288 |
| Operating Cash Flow | -€3,369 | -€6,358 | -€5,374 | -€6,250 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -€33 | -€44 | -€41 | -€151 |
| Net Acquisitions | €100 | €0 | -€397 | €0 |
| Inv. Purchases | €0 | -€18 | -€21 | €0 |
| Inv. Sales/Matur. | €10 | €0 | €418 | €0 |
| Other Inv. Act. | €0 | €0 | €365 | €0 |
| Investing Cash Flow | €77 | -€61 | €324 | -€151 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -€1,052 | -€1,456 | €999 | -€475 |
| Stock Issued | €337 | €2,929 | €676 | €8,149 |
| Stock Repurch. | €0 | €0 | €0 | €0 |
| Dividends Paid | €0 | €0 | €0 | €0 |
| Other Fin. Act. | €68 | €743 | -€44 | €39 |
| Financing Cash Flow | -€646 | €2,216 | €1,631 | €7,714 |
| Forex Effect | €0 | €0 | €7,007 | -€4,506 |
| Net Chg. in Cash | -€3,938 | -€4,203 | €3,588 | -€3,192 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | €4,905 | €9,108 | €5,520 | €8,712 |
| End Cash | €967 | €4,905 | €9,108 | €5,520 |
| Free Cash Flow | -€3,401 | -€6,402 | -€5,415 | -€6,400 |